tiprankstipranks
Blurbs

Analysts Are Bullish on These Healthcare Stocks: Danaher (DHR), IQVIA Holdings (IQV)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Danaher (DHRResearch Report) and IQVIA Holdings (IQVResearch Report) with bullish sentiments.

Danaher (DHR)

In a report released today, Paul Knight from KeyBanc maintained a Buy rating on Danaher, with a price target of $325.00. The company’s shares closed last Thursday at $279.23.

According to TipRanks.com, Knight is a 4-star analyst with an average return of 7.2% and a 49.5% success rate. Knight covers the Healthcare sector, focusing on stocks such as West Pharmaceutical Services, Castle Biosciences, and Stevanato Group.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Danaher with a $314.20 average price target, which is a 14.3% upside from current levels. In a report issued on July 13, Barclays also maintained a Buy rating on the stock with a $290.00 price target.

See today’s best-performing stocks on TipRanks >>

IQVIA Holdings (IQV)

In a report released today, Tejas Savant from Morgan Stanley maintained a Buy rating on IQVIA Holdings, with a price target of $260.00. The company’s shares closed last Thursday at $225.63.

According to TipRanks.com, Savant is a 1-star analyst with an average return of -5.5% and a 40.3% success rate. Savant covers the Healthcare sector, focusing on stocks such as Adaptive Biotechnologies, Pacific Biosciences, and Akoya Biosciences.

IQVIA Holdings has an analyst consensus of Strong Buy, with a price target consensus of $261.73, a 19.5% upside from current levels. In a report issued on July 7, Robert W. Baird also maintained a Buy rating on the stock with a $260.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on DHR:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More